Penetration of intravesical doxorubicin in human bladders

[1]  Thomas D. Schmittgen,et al.  Correlation of human bladder tumor histoculture proliferation and sensitivity to mitomycin C with tumor pathobiology. , 1994, The Journal of urology.

[2]  R. Badalament,et al.  Pharmacokinetics of intravesical doxorubicin in superficial bladder cancer patients. , 1994, The Journal of urology.

[3]  T. Saika,et al.  [Tissue concentration of intravesically instilled (2"R)-4'-o-tetrahydropyranyl-adriamycin or adriamycin in superficial bladder cancer]. , 1993, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

[4]  W. See,et al.  Regional chemotherapy for bladder neoplasms using continuous intravesical infusion of doxorubicin: impact of concomitant administration of dimethyl sulfoxide on drug absorption and antitumor activity. , 1992, Journal of the National Cancer Institute.

[5]  J. Drago,et al.  Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer patients. , 1991, Cancer research.

[6]  J. Drago,et al.  Bladder wall penetration of intravesical mitomycin C in dogs. , 1991, Cancer research.

[7]  D. Trump,et al.  Intravesical thiotepa versus mitomycin C in patients with Ta, T1 and TIS transitional cell carcinoma of the bladder: a phase III prospective randomized study. , 1988, The Journal of urology.

[8]  V. Laudone,et al.  An overview of intravesical therapy for superficial bladder tumors. , 1987, The Journal of urology.

[9]  T. Nakada,et al.  Intravesical instillation of doxorubicin hydrochloride and its incorporation into bladder tumors. , 1985, The Journal of urology.

[10]  F. Pannuti,et al.  Plasma Absorption and Tissue Concentrations of Adriamycin During Intravesical Therapy , 1985 .

[11]  J. Mcvie,et al.  Pharmacokinetics of mitomycin C in humans. , 1983, Cancer research.

[12]  K. Kurth,et al.  Studies on the intravesical action of topically administered G3H-doxorubicin hydrochloride in men: plasma uptake and tumor penetration. , 1980, The Journal of urology.

[13]  M. Soloway.  Rationale for intensive intravesical chemotherapy for superficial bladder cancer. , 1980, The Journal of urology.

[14]  Alberts Ds,et al.  Tabular summary of pharmacokinetic parameters relevant to in vitro drug assay. , 1980 .

[15]  D. Alberts,et al.  Tabular summary of pharmacokinetic parameters relevant to in vitro drug assay. , 1980, Progress in clinical and biological research.

[16]  S. Crooke,et al.  Phase I study of oral mitomycin C. , 1976, Cancer treatment reports.

[17]  J. Gross,et al.  Preliminary pharmacokinetic model for adriamycin (NSC-123127). , 1975, Cancer chemotherapy reports.

[18]  D. Wallace.  Cancer of the bladder. , 1968, The American journal of roentgenology, radium therapy, and nuclear medicine.

[19]  J. Cuellar.  [Cancer of the bladder]. , 1951, Vida nueva.